Differential features of nasopharyngeal carcinoma in children and adults: A SEER study

Pediatric Blood and Cancer

Volumn 55, Issue 2, 2010, Pages 279-284

  Sultan, Iyad ^a   Casanova, Michela ^b   Ferrari, Andrea ^b   Rihani, Rawad ^a   Rodriguez Galindo, Carlos ^c  

^a KING HUSSEIN CANCER CENTER   (Jordan)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Adolescents; Children; Nasopharyngeal carcinoma; Prognosis; SEER

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; DATA BASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NEGRO; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SECOND CANCER; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; AGE FACTORS; CHILD; CONTINENTAL POPULATION GROUPS; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASMS, SECOND PRIMARY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955107699     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22521     Document Type: Article

References (18)

1. Sun LM, Li CI, Huang EY, et al. Survival differences by race in nasopharyngeal carcinoma. Am J Epidemiol 2007;165:271-278.
2. Bray F, Haugen M, Moger TA, et al. Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev 2008;17:2356-2365.
3. Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Limited-Use, Nov 2008 Sub (1973-2006) 〈Katrina/Rita Population Adjustment〉 - Linked To County Attributes - Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009,based on the November 2008 submission.
4. Green FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. Philadelphia: Lippincott-Raven; 2002.
5. Jenkin RD, Anderson JR, Jereb B, et al. Nasopharyngeal carcinoma - A retrospective review of patients less than thirty years of age: A report of Children's Cancer Study Group. Cancer 1981;47:360-366.
6. Ingersoll L,Woo SY, Donaldson S, et al. Nasopharyngeal carcinoma in the young: A combined M.D. Anderson and Stanford experience. Int J Radiat Oncol Biol Phys 1990;19:881-887.
7. Richey LM, Olshan AF, George J, et al. Incidence and survival rates for young blacks with nasopharyngeal carcinoma in the United States. Arch Otolaryngol Head Neck Surg 2006;132:1035-1040.
8. Rodriguez-Galindo C, Wofford M, Castleberry RP, et al. Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma. Cancer 2005;103:850-857.
9. Mertens R, Granzen B, Lassay L, et al. Treatment of nasopharyngeal carcinoma in children and adolescents: Definitive results of a multicenter study (NPC-91-GPOH). Cancer 2005;104:1083-1089. (Pubitemid 41170238)
10. Ozyar E, Selek U, Laskar S, et al. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A rare cancer network study. Radiother Oncol 2006;81:39-46.
11. Downing NL, Wolden S, Wong P, et al. Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2009;75(4):1064-1070.
12. Scelo G, Boffetta P, Corbex M, et al. Second primary cancers in patients with nasopharyngeal carcinoma: A pooled analysis of 13 cancer registries. Cancer Causes Control 2007;18:269-278.
13. Khabir A, Karray H, Rodriguez S, et al. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. Virol J 2005;2:39.
14. Khabir A, Ghorbel A, Daoud J, et al. Similar BCL-X but different BCL-2 levels in the two age groups of North African nasopharyngeal carcinomas. Cancer Detect Prev 2003;27:250-255. (Pubitemid 36990242)
15. Ayadi W, Karray-Hakim H, Feki L, et al. IgA antibodies against the Epstein-Barr nuclear antigen1 as a valuable biomarker for the diagnosis of nasopharyngeal carcinoma in Tunisian patients. J Med Virol 2009;81:1412-1421.
16. Ayadi W, Feki L, Khabir A, et al. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients. Virus Genes 2007;34:137-145.
17. Ferrari A, Bleyer A. Participation of adolescents with cancer in clinical trials. Cancer Treat Rev 2007;33:603-608. (Pubitemid 350047371)
18. Pastore G, De Salvo GL, Bisogno G, et al. Evaluating access to pediatric cancer care centers of children and adolescents with rare tumors in Italy: The TREP project. Pediatr Blood Cancer 2009;53:152-155.